EXHIBIT 99.2



     Sunnyvale, Calif., August 3, 1998 -- Genus, Inc. (OTC, NASDAQ: GGNS), today
announced that it reached an agreement to buy back a significant portion of the
$5 million of Series A Convertible Preferred Stock that was issued in February
to a group of investors as part of a private placement agreement.  This
initiative allowed the Company to redeem $3.5 million of the outstanding
Series A shares for cash and to exchange the remaining Series A shares for
Series B Convertible Preferred Stock which has a fixed conversion price of
$1.25.

     "The recent sale of our ion implant assets to Varian Associates, Inc. gave
us the additional cash resources needed to make this happen," commented William
W.R. Elder, Genus chairman and CEO.  "We believe that this action is in the best
interest of Genus' shareholders as it will minimize dilution."

     Founded in 1982, Genus, Inc. designs, manufactures and markets thin films
and thin film deposition equipment used in the fabrication of advanced
semiconductor devices.  The Company's customers include semiconductor
manufacturers located throughout the United States, Europe and the Pacific Rim
including Korea, Japan and Taiwan.  Headquartered in California, Genus' offices
are located at 1139 Karlstad Drive, Sunnyvale, CA 94089; telephone (408)
747-7120; fax (408) 747-7199.  For the most up-to-date company, product and
financial information, visit Genus' new web site at http://www.genus.com.

     This release contains forward looking statements dependent on a number of
risks and uncertainties, including, but not limited, retrenchment in the
semiconductor industry, general conditions in the Company's industry sector, and
the additional risks and uncertainties detailed under "Management's Discussion
and Analysis of Results of Operations and Financial Condition" contained in the
Company's Annual Report on Form 10-K for the fiscal year ended December 31,
1997, and the Company's quarterly report on Form 10-Q for the quarter ended
March 31, 1998.